KB-DG

Executive Summary

KB-DG (Knox Biomedical Development Group) is a US-based consulting firm headquartered in San Diego, California, specializing in guiding biotechnology, medical technology, and pharmaceutical startups through product development and commercialization. Founded in 2015, the company offers expert services in process development, CMC, GMP manufacturing scale-up, validation, and quality assurance, helping early-stage companies efficiently transition from bench to market. As a private entity with no disclosed funding or valuation, KB-DG operates as a service provider rather than a product developer, positioning itself as a strategic partner for startups navigating complex regulatory and manufacturing landscapes. The firm's revenue is generated through consulting engagements, and its growth is tied to the broader life sciences ecosystem's demand for specialized expertise.

Upcoming Catalysts (preview)

• Q3 2026Announcement of Major Contract with a High-Profile Biotech Startup50% success
• Q4 2026Expansion of Service Offerings into New Therapeutic Areas (e.g., Gene Therapy or Cell Therapy)40% success
• TBDPartnership or Strategic Alliance with a CRO or CDMO to Provide Integrated Services35% success